QTMeds

Drug Database Monograph

ZIIHERA 300 mg

PENDING REVIEW

Active Ingredient: ZANIDATAMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 64817495

← Back to Prescription Analyzer